These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1516645)

  • 1. L-687,306: a functionally selective and potent muscarinic M1 receptor agonist.
    Freedman SB; Patel S; Harley EA; Iversen LL; Baker R; Showell GA; Saunders J; McKnight A; Newberry N; Scholey K
    Eur J Pharmacol; 1992 Apr; 215(1):135-6. PubMed ID: 1516645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro biological profile of all four isomers of the potent muscarinic agonist 3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane.
    Showell GA; Baker R; Davis J; Hargreaves R; Freedman SB; Hoogsteen K; Patel S; Snow RJ
    J Med Chem; 1992 Mar; 35(5):911-6. PubMed ID: 1548680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of (+/-)L-660,863 [(+/-)3-(3-amino-1,2,4-oxadiazole-5-yl)-quinuclidine] at muscarinic receptor subtypes in vitro.
    Eglen RM; Harris GC; Ford AP; Wong EH; Pfister JR; Whiting RL
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):375-81. PubMed ID: 1620240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.
    Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ
    Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
    Dawson GR; Iversen SD
    Behav Brain Res; 1993 Nov; 57(2):143-53. PubMed ID: 8117420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacological study of the responses induced by muscarinic agonists on the isolated superior cervical ganglion of the guinea-pig.
    Roberts KE; Newberry NR
    Eur J Pharmacol; 1990 Sep; 186(2-3):257-65. PubMed ID: 2289527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
    Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
    Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system.
    North RA; Slack BE; Surprenant A
    J Physiol; 1985 Nov; 368():435-52. PubMed ID: 4078746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
    Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
    Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
    Rupniak NM; Patel S; Marwood R; Webb J; Traynor JR; Elliott J; Freedman SB; Fletcher SR; Hill RG
    Br J Pharmacol; 1994 Dec; 113(4):1487-93. PubMed ID: 7889306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.
    Reddy H; Watson N; Ford AP; Eglen RM
    Br J Pharmacol; 1995 Jan; 114(1):49-56. PubMed ID: 7712028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
    Ward JS; Merritt L; Calligaro DO; Bymaster FP; Shannon HE; Sawyer BD; Mitch CH; Deeter JB; Peters SC; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P
    J Med Chem; 1995 Sep; 38(18):3469-81. PubMed ID: 7658434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDZ ENS 163 is a selective M1 agonist and induces release of acetylcholine.
    Enz A; Shapiro G; Supavilai P; Boddeke HW
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):282-7. PubMed ID: 1620233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic M1 and M3 receptor antagonist effects of a new pirenzepine analogue in isolated guinea-pig ileal longitudinal muscle-myenteric plexus.
    Barocelli E; Ballabeni V; Chiavarini M; Molina E; Lavezzo A; Impicciatore M
    Eur J Pharmacol; 1994 Mar; 254(1-2):151-7. PubMed ID: 7515819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.